NRC HEALTH (NRC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q3 '16: 27M Q4 '16: 28.4M Q1 '17: 30.3M Q2 '17: 28.4M Q3 '17: 29M Q4 '17: 29.9M Q1 '18: 31M Q2 '18: 28M Q3 '18: 30M Q4 '18: 30.6M Q1 '19: 31.5M Q2 '19: 31.4M Q3 '19: 32.5M Q4 '19: 32.6M Q1 '20: 33.9M Q2 '20: 31.2M Q3 '20: 33.5M Q4 '20: 34.8M Q1 '21: 35.5M Q2 '21: 36.4M Q3 '21: 37.8M Q4 '21: 38.3M Q1 '22: 38.4M Q2 '22: 37.3M Q3 '22: 37.7M Q4 '22: 38.1M Q1 '23: 36.5M Q2 '23: 36.2M Q3 '23: 37.9M Q4 '23: 38M Q1 '24: 35.3M Q2 '24: 35M Q3 '24: 35.8M Q4 '24: 36.9M Q1 '25: 33.6M Q2 '25: 34M Q3 '25: 34.6M Q4 '25: 35.2M Q1 '26: 34.8M Q2 '26: 35.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-5M 0 5M 10M 15M Q3 '16: 7.3M Q4 '16: 8.8M Q1 '17: 10M Q2 '17: 8.5M Q3 '17: 7.1M Q4 '17: 8.7M Q1 '18: 9M Q2 '18: 7.8M Q3 '18: 9.2M Q4 '18: 9.4M Q1 '19: 10.7M Q2 '19: 10.1M Q3 '19: 10.2M Q4 '19: 12M Q1 '20: 11.2M Q2 '20: 9.3M Q3 '20: 12M Q4 '20: 10.2M Q1 '21: 12M Q2 '21: 12.2M Q3 '21: 13.1M Q4 '21: 12.9M Q1 '22: 11.7M Q2 '22: 11.5M Q3 '22: 11.1M Q4 '22: 12.2M Q1 '23: 9M Q2 '23: 9.4M Q3 '23: 10M Q4 '23: 11.7M Q1 '24: 8.8M Q2 '24: 8.9M Q3 '24: 8M Q4 '24: 9.6M Q1 '25: 8.6M Q2 '25: 1.6M Q3 '25: 7.7M Q4 '25: 4.7M Q1 '26: 5.6M Q2 '26: -3.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-4M 0 4M 8M 12M Q3 '16: 4.7M Q4 '16: 5.7M Q1 '17: 6.5M Q2 '17: 5.8M Q3 '17: 4.2M Q4 '17: 6.5M Q1 '18: 7.3M Q2 '18: 7.9M Q3 '18: 7M Q4 '18: 7.8M Q1 '19: 8.2M Q2 '19: 7.4M Q3 '19: 8.1M Q4 '19: 8.7M Q1 '20: 11.8M Q2 '20: 7.7M Q3 '20: 9.6M Q4 '20: 8.2M Q1 '21: 9.2M Q2 '21: 8.9M Q3 '21: 9.7M Q4 '21: 9.6M Q1 '22: 8.5M Q2 '22: 8.3M Q3 '22: 8.3M Q4 '22: 6.6M Q1 '23: 7M Q2 '23: 7.3M Q3 '23: 7.9M Q4 '23: 8.9M Q1 '24: 6.4M Q2 '24: 6.2M Q3 '24: 5.7M Q4 '24: 6.6M Q1 '25: 5.8M Q2 '25: -106K Q3 '25: 4.1M Q4 '25: 1.8M Q1 '26: 3.2M Q2 '26: -3.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-6M 0 6M 12M 18M Q3 '16: 6.8M Q4 '16: 8.8M Q1 '17: 8.1M Q2 '17: 2.5M Q3 '17: 10.9M Q4 '17: 6.6M Q1 '18: 8.2M Q2 '18: 10.2M Q3 '18: 7.5M Q4 '18: 13.9M Q1 '19: 7.3M Q2 '19: 8.8M Q3 '19: 12.9M Q4 '19: 11.9M Q1 '20: 5.5M Q2 '20: 8.4M Q3 '20: 10.5M Q4 '20: 16.2M Q1 '21: 14.4M Q2 '21: 11.2M Q3 '21: 8.7M Q4 '21: 12.1M Q1 '22: 8.3M Q2 '22: 9.8M Q3 '22: 10.1M Q4 '22: 8.1M Q1 '23: 7.8M Q2 '23: 8.8M Q3 '23: 9.8M Q4 '23: 11.7M Q1 '24: 12M Q2 '24: 6.8M Q3 '24: 9.4M Q4 '24: 6.4M Q1 '25: 6.6M Q2 '25: -1.1M Q3 '25: 13.8M Q4 '25: 7.2M Q1 '26: 7.2M Q2 '26: 1.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-5M 0 5M 10M 15M Q3 '16: 5.9M Q4 '16: 7.9M Q1 '17: 6.7M Q2 '17: 1.5M Q3 '17: 9.9M Q4 '17: 5.4M Q1 '18: 6.9M Q2 '18: 8.7M Q3 '18: 5.5M Q4 '18: 12.8M Q1 '19: 6.2M Q2 '19: 7.7M Q3 '19: 11.7M Q4 '19: 10.7M Q1 '20: 4.9M Q2 '20: 7.5M Q3 '20: 9.5M Q4 '20: 14.7M Q1 '21: 13.2M Q2 '21: 9.6M Q3 '21: 7.7M Q4 '21: 10.4M Q1 '22: 5.7M Q2 '22: 8.5M Q3 '22: 6.1M Q4 '22: 6.1M Q1 '23: 4.6M Q2 '23: 4.5M Q3 '23: 5.3M Q4 '23: 7.9M Q1 '24: 7.9M Q2 '24: 1.5M Q3 '24: 7.8M Q4 '24: 1.9M Q1 '25: 3.7M Q2 '25: -4.1M Q3 '25: 10.2M Q4 '25: 6.1M Q1 '26: 5.3M Q2 '26: 62K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q2 '10: 6.7M Q3 '10: 6.7M Q1 '11: 6.8M Q2 '11: 6.9M Q3 '11: 6.8M Q1 '12: 6.9M Q2 '12: 6.9M Q3 '12: 7M Q1 '13: 7M Q1 '19: 25.5M Q2 '19: 25.6M Q3 '19: 25.7M Q1 '20: 25.7M Q2 '20: 25.7M Q3 '20: 25.7M Q1 '21: 25.7M Q2 '21: 25.6M Q3 '21: 25.6M Q1 '22: 25.4M Q2 '22: 25.2M Q3 '22: 24.8M Q1 '23: 24.7M Q2 '23: 24.7M Q3 '23: 24.7M Q1 '24: 24M Q2 '24: 23.9M Q3 '24: 23.7M Q1 '25: 23M Q2 '25: 22.7M Q3 '25: 22.1M Q1 '26: 21.9M Q2 '26: 22M Q2 '11 Q3 '12 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 20.00 40.00 60.00 Q4 '10: 1.26 Q1 '11: 1.31 Q2 '11: 1.40 Q3 '11: 1.47 Q4 '11: 1.70 Q1 '12: 1.75 Q2 '12: 1.98 Q3 '12: 2.10 Q4 '12: 2.17 Q1 '13: 2.25 Q4 '19: 1.26 Q1 '20: 1.40 Q2 '20: 1.41 Q3 '20: 1.47 Q4 '20: 1.45 Q1 '21: 1.35 Q2 '21: 1.40 Q3 '21: 1.41 Q4 '21: 1.47 Q1 '22: 1.45 Q2 '22: 1.43 Q3 '22: 1.38 Q4 '22: 1.27 Q1 '23: 1.21 Q2 '23: 1.17 Q3 '23: 1.16 Q4 '23: 1.25 Q1 '24: 1.24 Q2 '24: 1.21 Q3 '24: 1.13 Q4 '24: 1.05 Q1 '25: 1.03 Q2 '25: 0.76 Q3 '25: 0.70 Q4 '25: 49.99 Q1 '26: 49.88 Q2 '26: 49.74 Q1 '11 Q2 '12 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.